首页|血清CCL16对乙型肝炎肝硬化失代偿期患者预后预测的临床价值

血清CCL16对乙型肝炎肝硬化失代偿期患者预后预测的临床价值

Clinical value of serum CCL16 in prognosis prediction of patients with decompensated hepatitis B cirrhosis

扫码查看
目的 探讨血清CC趋化因子配体16(CCL16)对乙型肝炎肝硬化失代偿期患者预后预测的临床价值.方法 选择2021年9月至2022年9月三二〇一医院收治的100例乙型肝炎肝硬化失代偿期患者作为研究对象.根据Child-Pugh评分及分级标准,将患者分为Child-Pugh A级组(n=30)、Child-Pugh B级组(n=38)、Child-Pugh C级组(n=32);根据随访 6个月的预后情况,将患者分为生存组(n=58)和死亡组(n=42).比较各组血清CCL16水平及相关指标;采用logistic回归模型分析探讨影响乙型肝炎肝硬化失代偿期患者预后的因素;采用ROC曲线分析血清CCL16 对乙型肝炎肝硬化失代偿期患者预后的预测效能.结果 Child-Pugh A级组、Child-Pugh B级组、Child-Pugh C级组的血清CCL16水平依次降低,差异有统计学意义(P<0.05).与生存组相比,死亡组的白细胞计数、HBV-DNA、总胆红素(Tbil)水平、Child-Pugh评分均显著升高,血清CCL16水平显著降低(P均<0.05).多因素logistic回归模型分析结果显示,血清CCL16、白细胞计数、HBV-DNA、Tbil、Child-Pugh评分均是乙型肝炎肝硬化失代偿期患者预后的影响因素(P均<0.05).ROC曲线分析结果显示,血清CCL16 预测乙型肝炎肝硬化失代偿期患者预后的曲线下面积(AUC)为 0.921,特异度为 97.62%,敏感度为74.14%.结论 血清CCL16 水平与乙型肝炎肝硬化失代偿期患者的病情严重程度及预后密切相关,其随着患者病情严重程度的加重而显著降低,并且其对患者预后的预测效能较高.
Objective This paper intends to explore the clinical value of serum chemokine CC motif ligand 16(CCL16)in predicting the prognosis of patients with decompensated hepatitis B cirrhosis.Methods A hundred patients with decompensated hepatitis B cirrhosis admitted to 3201 Hospital from September 2021 to September 2022 were selected as the study subjects.According to the Child-Pugh score and grading criteria,the patients were divided into the Child-Pugh A group(n=30),the Child-Pugh B group(n=38),and the Child-Pugh C group(n=32).Based on the 6-month follow-up prognosis,the patients were assigned into the survival group(n=58)and the death group(n=42).The serum CCL16 levels and other related indicators of each group were compared.The logistic regression analysis was conducted to explore the factors affecting the prognosis of patients with decompensated hepatitis B cirrhosis.The ROC curve analysis was performed to predict the prognostic efficacy of serum CCL16 in patients with decompensated hepatitis B cirrhosis.Results The serum CCL16 levels in the Child-Pugh A group,the Child-Pugh B group,and the Child-Pugh C group decrease sequentially,with a statistically significant difference(P<0.05).Compared with the survival group,the white blood cell count,the HBV-DNA,the TBil level,and the Child-Pugh score are significantly increased,while the serum CCL16 level is significantly decreased(P<0.05).The results of multivariate logistic regression analysis shows that the serum CCL16,the white blood cell count,the HBV-DNA,the TBil level,and the Child-Pugh scores are influencing factors for the prognosis of patients with decompensated hepatitis B cirrhosis(P<0.05).The ROC curve analysis indicates that the area under the curve(AUC)of serum CCL16 predicting the prognosis of patients with decompensated hepatitis B cirrhosis is 0.921,with a specificity of 97.62%and a sensitivity of 74.14%.Conclusions The serum CCL16 level is closely related to the severity and prognosis of patients with decompensated hepatitis B cirrhosis.It significantly decreases with the severity of the patient's condition,and its predictive power for patient prognosis is high.

Chemokine CC motif ligand 16Hepatitis B cirrhosisDecompensationPrognosisClinical value

田婉婷、吴光辉、王超智

展开 >

723000 陕西汉中,三二〇一医院消化内科

CC趋化因子配体16 乙型肝炎肝硬化 失代偿期 预后 临床价值

2024

国际消化病杂志
上海市医学科学技术情报研究所

国际消化病杂志

CSTPCD
影响因子:0.796
ISSN:1673-534X
年,卷(期):2024.44(3)